Schellenberg Wittmer advised Swisscanto Private Equity. Swisscanto Private Equity completed the CHF 8.3 million Series B financing of the leading innovator in ultrasonic camera technology Distran....
Swisscanto Private Equity’s Series B Financing Of Distran
Santhera Pharmaceuticals’ License Agreement With Catalyst Pharmaceuticals
Schellenberg Wittmer advises Santhera on license for North America for Vamorolone. Santhera Pharmaceuticals (SIX: SANN) has signed an exclusive license and collaboration agreement for vamorolone in...